Fig. 2From: 18F-FDG and 11C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective studyKaplan-Meier analysis for progression-free survival (PFS) in patients with advanced non-small-cell lung cancer treated with platinum-based doublet chemotherapy (PT-DC). a PFS according to metabolic tumor volume (MTV) of baseline 4DST. b PFS according to MTV of baseline FDGBack to article page